Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 Aug;87(2):93–96. doi: 10.1136/adc.87.2.93

The impact of corticosteroids on growth and bone health

T Mushtaq 1, S Ahmed 1
PMCID: PMC1719206  PMID: 12138051

Full Text

The Full Text of this article is available as a PDF (92.8 KB).

Figure 1 .

Figure 1

Open in a new tab

Mechanisms of GC induced bone loss and growth retardation.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi J. D., Bensen W. G., Brown J., Hanley D., Hodsman A., Josse R., Kendler D. L., Lentle B., Olszynski W., Ste-Marie L. G. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):382–387. doi: 10.1056/NEJM199708073370603. [DOI] [PubMed] [Google Scholar]
  2. Agertoft L., Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med. 1998 Jan;157(1):178–183. doi: 10.1164/ajrccm.157.1.9707072. [DOI] [PubMed] [Google Scholar]
  3. Ahmed S. F., Wallace W. H., Crofton P. M., Wardhaugh B., Magowan R., Kelnar C. J. Short-term changes in lower leg length in children treated for acute lymphoblastic leukaemia. J Pediatr Endocrinol Metab. 1999 Jan-Feb;12(1):75–80. doi: 10.1515/jpem.1999.12.1.75. [DOI] [PubMed] [Google Scholar]
  4. Allen D. B., Mullen M., Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol. 1994 Jun;93(6):967–976. doi: 10.1016/s0091-6749(94)70043-5. [DOI] [PubMed] [Google Scholar]
  5. Arikoski P., Komulainen J., Riikonen P., Jurvelin J. S., Voutilainen R., Kröger H. Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child. 1999 Feb;80(2):143–148. doi: 10.1136/adc.80.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Avioli L. V. Glucocorticoid effects on statural growth. Br J Rheumatol. 1993 May;32 (Suppl 2):27–30. doi: 10.1093/rheumatology/32.suppl_2.27. [DOI] [PubMed] [Google Scholar]
  7. BLODGETT F. M., BURGIN L., IEZZONI D., GRIBETZ D., TALBOT N. B. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med. 1956 Apr 5;254(14):636–641. doi: 10.1056/NEJM195604052541402. [DOI] [PubMed] [Google Scholar]
  8. Bar-On E., Beckwith J. B., Odom L. F., Eilert R. E. Effect of chemotherapy on human growth plate. J Pediatr Orthop. 1993 Mar-Apr;13(2):220–224. [PubMed] [Google Scholar]
  9. Baron J., Huang Z., Oerter K. E., Bacher J. D., Cutler G. B., Jr Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am J Physiol. 1992 Sep;263(3 Pt 1):E489–E492. doi: 10.1152/ajpendo.1992.263.3.E489. [DOI] [PubMed] [Google Scholar]
  10. Birkebaek N. H., Clausen N. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1998 Aug;79(2):161–164. doi: 10.1136/adc.79.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Boot A. M., Bouquet J., Krenning E. P., de Muinck Keizer-Schrama S. M. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998 Feb;42(2):188–194. doi: 10.1136/gut.42.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Broyer M., Terzi F., Lehnert A., Gagnadoux M. F., Guest G., Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol. 1997 Aug;11(4):418–422. doi: 10.1007/s004670050308. [DOI] [PubMed] [Google Scholar]
  13. Cassidy J. T., Hillman L. S. Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis. Rheum Dis Clin North Am. 1997 Aug;23(3):499–522. doi: 10.1016/s0889-857x(05)70345-8. [DOI] [PubMed] [Google Scholar]
  14. Chesney R. W., Rose P., Mazess R. B., DeLuca H. F. Long term follow-up of bone mineral status in children with renal disease. Pediatr Nephrol. 1988 Jan;2(1):22–26. doi: 10.1007/BF00870374. [DOI] [PubMed] [Google Scholar]
  15. Conti A., Sartorio A., Ferrero S., Ferrario S., Ambrosi B. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. J Endocrinol Invest. 1996 Feb;19(2):127–130. doi: 10.1007/BF03349848. [DOI] [PubMed] [Google Scholar]
  16. Cowan F. J., Parker D. R., Jenkins H. R. Osteopenia in Crohn's disease. Arch Dis Child. 1995 Sep;73(3):255–256. doi: 10.1136/adc.73.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cowan F. J., Warner J. T., Dunstan F. D., Evans W. D., Gregory J. W., Jenkins H. R. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child. 1997 Apr;76(4):325–329. doi: 10.1136/adc.76.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Crilly R., Cawood M., Marshall D. H., Nordin B. E. Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women. J R Soc Med. 1978 Oct;71(10):733–736. doi: 10.1177/014107687807101006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Crofton P. M., Ahmed S. F., Wade J. C., Elmlinger M. W., Ranke M. B., Kelnar C. J., Wallace W. H. Effects of a third intensification block of chemotherapy on bone and collagen turnover, insulin-like growth factor I, its binding proteins and short-term growth in children with acute lymphoblastic leukaemia. Eur J Cancer. 1999 Jun;35(6):960–967. doi: 10.1016/s0959-8049(99)00060-x. [DOI] [PubMed] [Google Scholar]
  20. Crofton P. M., Ahmed S. F., Wade J. C., Stephen R., Elmlinger M. W., Ranke M. B., Kelnar C. J., Wallace W. H. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998 Sep;83(9):3121–3129. doi: 10.1210/jcem.83.9.5133. [DOI] [PubMed] [Google Scholar]
  21. Davies H. A., Didcock E., Didi M., Ogilvy-Stuart A., Wales J. K., Shalet S. M. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child. 1994 Jun;70(6):472–475. doi: 10.1136/adc.70.6.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Doull I. J., Campbell M. J., Holgate S. T. Duration of growth suppressive effects of regular inhaled corticosteroids. Arch Dis Child. 1998 Feb;78(2):172–173. doi: 10.1136/adc.78.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Eastell R., Reid D. M., Compston J., Cooper C., Fogelman I., Francis R. M., Hosking D. J., Purdie D. W., Ralston S. H., Reeve J. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med. 1998 Oct;244(4):271–292. doi: 10.1046/j.1365-2796.1998.00408.x. [DOI] [PubMed] [Google Scholar]
  24. Edsbäcker S., Andersson K. E., Ryrfeldt A. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol. 1985;29(4):477–481. doi: 10.1007/BF00613465. [DOI] [PubMed] [Google Scholar]
  25. Gabrielsson B. G., Carmignac D. F., Flavell D. M., Robinson I. C. Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology. 1995 Jan;136(1):209–217. doi: 10.1210/endo.136.1.7828533. [DOI] [PubMed] [Google Scholar]
  26. Glorieux F. H., Bishop N. J., Plotkin H., Chabot G., Lanoue G., Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998 Oct 1;339(14):947–952. doi: 10.1056/NEJM199810013391402. [DOI] [PubMed] [Google Scholar]
  27. Hahn T. J., Halstead L. R., Teitelbaum S. L., Hahn B. H. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979 Aug;64(2):655–665. doi: 10.1172/JCI109506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Halton J. M., Atkinson S. A., Fraher L., Webber C., Gill G. J., Dawson S., Barr R. D. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res. 1996 Nov;11(11):1774–1783. doi: 10.1002/jbmr.5650111122. [DOI] [PubMed] [Google Scholar]
  29. Halton J. M., Atkinson S. A., Fraher L., Webber C., Gill G. J., Dawson S., Barr R. D. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res. 1996 Nov;11(11):1774–1783. doi: 10.1002/jbmr.5650111122. [DOI] [PubMed] [Google Scholar]
  30. Heuck C., Ternowitz T., Herlin T., Wolthers O. D. Knemometry in children with atopic dermatitis treated with topical glucocorticoids. Pediatr Dermatol. 1998 Jan-Feb;15(1):7–11. doi: 10.1046/j.1525-1470.1998.1998015007.x. [DOI] [PubMed] [Google Scholar]
  31. Hofbauer L. C., Gori F., Riggs B. L., Lacey D. L., Dunstan C. R., Spelsberg T. C., Khosla S. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology. 1999 Oct;140(10):4382–4389. doi: 10.1210/endo.140.10.7034. [DOI] [PubMed] [Google Scholar]
  32. Hsueh A. J., Erickson G. F. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells. Steroids. 1978 Dec;32(5):639–648. doi: 10.1016/0039-128x(78)90074-0. [DOI] [PubMed] [Google Scholar]
  33. Hughes N. R., Lissett C. A., Shalet S. M. Growth hormone status following treatment for Cushing's syndrome. Clin Endocrinol (Oxf) 1999 Jul;51(1):61–66. doi: 10.1046/j.1365-2265.1999.00738.x. [DOI] [PubMed] [Google Scholar]
  34. Jabs K., Sullivan E. K., Avner E. D., Harmon W. E. Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation. 1996 Jan 15;61(1):31–36. doi: 10.1097/00007890-199601150-00008. [DOI] [PubMed] [Google Scholar]
  35. Jux C., Leiber K., Hügel U., Blum W., Ohlsson C., Klaus G., Mehls O. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology. 1998 Jul;139(7):3296–3305. doi: 10.1210/endo.139.7.6099. [DOI] [PubMed] [Google Scholar]
  36. Kadan-Lottick N., Marshall J. A., Barón A. E., Krebs N. F., Hambidge K. M., Albano E. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr. 2001 Jun;138(6):898–904. doi: 10.1067/mpd.2001.113102. [DOI] [PubMed] [Google Scholar]
  37. Kamischke A., Kemper D. E., Castel M. A., Lüthke M., Rolf C., Behre H. M., Magnussen H., Nieschlag E. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J. 1998 Jan;11(1):41–45. doi: 10.1183/09031936.98.11010041. [DOI] [PubMed] [Google Scholar]
  38. Kaste S. C., Jones-Wallace D., Rose S. R., Boyett J. M., Lustig R. H., Rivera G. K., Pui C. H., Hudson M. M. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia. 2001 May;15(5):728–734. doi: 10.1038/sj.leu.2402078. [DOI] [PubMed] [Google Scholar]
  39. Kimura Y., Fieldston E., Devries-Vandervlugt B., Li S., Imundo L. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2000 Aug;27(8):2018–2024. [PubMed] [Google Scholar]
  40. Kotaniemi A., Savolainen A., Kröger H., Kautiainen H., Isomäki H. Development of bone mineral density at the lumbar spine and femoral neck in juvenile chronic arthritis--a prospective one year followup study. J Rheumatol. 1998 Dec;25(12):2450–2455. [PubMed] [Google Scholar]
  41. Lettgen B., Jeken C., Reiners C. Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol. 1994 Dec;8(6):667–670. doi: 10.1007/BF00869084. [DOI] [PubMed] [Google Scholar]
  42. Markowitz J., Grancher K., Rosa J., Aiges H., Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993 May;16(4):373–380. doi: 10.1097/00005176-199305000-00005. [DOI] [PubMed] [Google Scholar]
  43. Pantelakis S. N., Sinaniotis C. A., Sbirakis S., Ikkos D., Doxiadis S. A. Night and day growth hormone levels during treatment with corticosteroids and corticotrophin. Arch Dis Child. 1972 Aug;47(254):605–608. doi: 10.1136/adc.47.254.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pedersen S. Assessing the effect of intranasal steroids on growth. J Allergy Clin Immunol. 2001 Jul;108(1 Suppl):S40–S44. doi: 10.1067/mai.2001.115565. [DOI] [PubMed] [Google Scholar]
  45. Polito C., La Manna A., Papale M. R., Villani G. Delayed pubertal growth spurt and normal adult height attainment in boys receiving long-term alternate-day prednisone therapy. Clin Pediatr (Phila) 1999 May;38(5):279–285. doi: 10.1177/000992289903800505. [DOI] [PubMed] [Google Scholar]
  46. Robinson R. J., Iqbal S. J., Whitaker R. P., Abrams K., Mayberry J. F. Rectal steroids suppress bone formation in patients with colitis. Aliment Pharmacol Ther. 1997 Feb;11(1):201–204. doi: 10.1046/j.1365-2036.1997.123294000.x. [DOI] [PubMed] [Google Scholar]
  47. Robson H., Anderson E., Eden O. B., Isaksson O., Shalet S. Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation. J Endocrinol. 1998 May;157(2):225–235. doi: 10.1677/joe.0.1570225. [DOI] [PubMed] [Google Scholar]
  48. Rooney M., Davies U. M., Reeve J., Preece M., Ansell B. M., Woo P. M. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol. 2000 Apr;27(4):1073–1081. [PubMed] [Google Scholar]
  49. Saha M. T., Laippala P., Lenko H. L. Normal growth of prepubertal nephrotic children during long-term treatment with repeated courses of prednisone. Acta Paediatr. 1998 May;87(5):545–548. doi: 10.1080/08035259850158263. [DOI] [PubMed] [Google Scholar]
  50. Saha M. T., Verronen P., Laippala P., Lenko H. L. Growth of prepubertal children with juvenile chronic arthritis. Acta Paediatr. 1999 Jul;88(7):724–728. doi: 10.1080/08035259950168991. [DOI] [PubMed] [Google Scholar]
  51. Sakakura M., Takebe K., Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab. 1975 May;40(5):774–779. doi: 10.1210/jcem-40-5-774. [DOI] [PubMed] [Google Scholar]
  52. Savage M. O., Beattie R. M., Camacho-Hübner C., Walker-Smith J. A., Sanderson I. R. Growth in Crohn's disease. Acta Paediatr Suppl. 1999 Feb;88(428):89–92. doi: 10.1111/j.1651-2227.1999.tb14360.x. [DOI] [PubMed] [Google Scholar]
  53. Schaefer F., Seidel C., Binding A., Gasser T., Largo R. H., Prader A., Schärer K. Pubertal growth in chronic renal failure. Pediatr Res. 1990 Jul;28(1):5–10. doi: 10.1203/00006450-199007000-00002. [DOI] [PubMed] [Google Scholar]
  54. Semeao E. J., Stallings V. A., Peck S. N., Piccoli D. A. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997 May;112(5):1710–1713. doi: 10.1016/s0016-5085(97)70055-6. [DOI] [PubMed] [Google Scholar]
  55. Shaw N. J., Fraser N. C., Weller P. H. Asthma treatment and growth. Arch Dis Child. 1997 Oct;77(4):284–286. doi: 10.1136/adc.77.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Strauss A. J., Su J. T., Dalton V. M., Gelber R. D., Sallan S. E., Silverman L. B. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001 Jun 15;19(12):3066–3072. doi: 10.1200/JCO.2001.19.12.3066. [DOI] [PubMed] [Google Scholar]
  57. Touati G., Ruiz J. C., Porquet D., Kindermans C., Prieur A. M., Czernichow P. Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol. 2000 May;27(5):1287–1293. [PubMed] [Google Scholar]
  58. Unterman T. G., Phillips L. S. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab. 1985 Oct;61(4):618–626. doi: 10.1210/jcem-61-4-618. [DOI] [PubMed] [Google Scholar]
  59. Warner J. O. Review of prescribed treatment for children with asthma in 1990. BMJ. 1995 Sep 9;311(7006):663–666. doi: 10.1136/bmj.311.7006.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Weinstein R. S., Jilka R. L., Parfitt A. M., Manolagas S. C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998 Jul 15;102(2):274–282. doi: 10.1172/JCI2799. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES